Botulinum Toxin (BTX)

(Table 6-21)
  • Purified protein toxin produced from Clostridium botulinum; seven serotypes which differ slightly in clinical effect and mechanism of action, but all block neuromuscular transmission causing temporary paralysis of striated muscle
  • BTX specifically inhibits acetylcholine (ACh) release by cleaving proteins in the SNARE complex (required for Ach release)
    • BTX type A light chain cleaves SNAP25 (synaptosome-associated protein), key protein for successful docking and release of ACh from vesicles within nerve endings
    • BTX type B light chain cleaves synaptobrevin or VAMP (vesicle-associated membrane protein)
  • BOTOX (type A): FDA-approved for glabellar rhytides and hyperhidrosis; each vial contains 50 or 100 units of vacuum-dried BTX A neurotoxin; smaller volume with higher dose keeps delivery precise with little diffusion
  • Instructions recommend reconstitution with sterile, non-preserved saline, but preserved saline results in less pain on injection and does not reduce stability of toxin
  • Contraindication: any neuromuscular disorder, infection/inflammation at injection site, known hypersensitivity to product or any of the contents, pregnancy (category C - safety for use during pregnancy has not been established) or breastfeeding
  • Most effective in reducing dynamic facial lines (vs. static lines) (Table 6-21)
  • Glabellar rhytides (procerus, corrugator supercilii):
    • Stay 1 cm above orbital rim
    • If BTX diffuses to levator palpebrae muscle, eyelid ptosis may occur
  • Horizontal forehead lines (frontalis muscle):
    • If weaken frontalis muscle significantly but eyebrow depressors not weakened concomitantly, will have unopposed action of depressors with lowering of the brow and an angry expression
    • If patient narrow brow (<12 cm) between temporal fusion lines at mid brow level, receive fewer injection site (four instead of five)
  • Crow’s feet (orbicularis oculi):
    • Weakening of orbicularis oculi muscle by three injection sites
    • Do not inject while patient is still smiling as toxin may affect ipsilateral zygomaticus complex, causing ptosis of upper lip
  • Perioral rhytides (orbicularis oris):
    • Vertical lines radiating outward from vermilion border due to overactive orbicularis oris
    • Goal to produce mild weakening of muscle (avoiding paresis, which would interfere with speech); small doses 1–2 units per lip quadrant sufficient (total eight injection sites)
  • Bunny lines (nasalis):
    • Inject anterior to nasofacial groove on lateral wall of nose to soften ‘bunny lines’ (radial lines fanning obliquely across radix of nose); inject superficial to angular vein
    • Avoid injecting nasofacial groove as this can affect levator labii superioris and levator superior alaeque nasi
  • Depressor anguli oris (DAO):
    • Contraction causes downward turn of corner of mouth, creating negative facial expression
    • Inject 3–5 units at level of mandible (posterior margin), close to anterior margin of masseter; complications include asymmetric smile and flaccid cheek
    • Patients using perioral muscles intensely are not good candidates for DAO injections
  • Complications:
    • Brow ptosis may occur while glabellar complex being treated if BTX inadvertently affects frontalis muscle; may also occur if frontalis muscle being treated in patient with already low-set eyebrows
    • Quizzical appearance may appear when horizontal forehead lines are treated without treatment of most lateral frontalis fibers, which results in upward pull from the nontreated fibers
    • Upper eyelid ptosis occurs typically with treatment of glabellar complex; toxin diffuses through orbital septum affecting upper eyelid levator muscle; appears as early as 48 h and as late as 14 days after treatment, lasts 2–12 weeks; avoid complication by injecting small volume with high concentration and always inject 1 cm above orbital rim; can treat with apraclonidine 0.5% eye drops, which is an α-adrenergic agonist and may lift lid by 1–2 mm (compensates for weakness of levator palpebrae superioris by causing Muller’s muscle to contract)
   
 
Table 6-21 Muscles Treated with BTX
 MuscleResulting RhytidesComments
 
Nasalis
 
Bunny lines (radial lines across radix of nose)
 
Avoid angular vein
 
Orbicularis oculi
Crow’s feet (horizontal to oblique lines radiating from lateral canthus)
 
Frontalis muscle
 
Horizontal forehead lines
 
Complications: quizzical appearance, brow ptosis
 
Procerus, corrugator supercilii
Glabellar lines
Complications: eyelid ptosis, brow ptosis (latter rare)